This whitepaper is brought to you by Quest Diagnostics.

Differences between clinical trial and real-world demographics have raised questions about whether safety and efficacy data can effectively show if benefits of a drug outweigh the risks in the intended use population. Access this valuable resource from Fierce Pharmato stay compliant with the latestFDA requirements and ensure the appropriate audience is recruited and enrolled for clinical trials.

Special Report: How sponsors can meet the FDA’s diversity action plan requirements

 We explore:

• How to leverage reliable data to define the targeted population for a therapy

• Tips for recruiting and enrolling the appropriate audience for a clinical trial

• Updates on the latest FDA requirements

• Ways to retool strategies to better understand the age, gender, location, race and ethnicity of potential trial participants

• And more